Eribulin versus Treatment of Physician’s Choice for Patients with Heavily Pretreated Advanced Breast Cancer
Submitted by jwr@option4.com on Sat, 07/17/2010 - 21:11
Activity of Bevacizumab in Combination with First- and Second-Line Chemotherapy for Metastatic Breast Cancer (mBC)
Submitted by jwr@option4.com on Sat, 07/17/2010 - 21:09
Combination Anti-HER2 Therapy with Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer (mBC) Previously Treated with Trastuzumab
Submitted by jwr@option4.com on Sat, 07/17/2010 - 21:08
Effect of Targeted Intraoperative Radiation Therapy on Local Recurrence Rate in Early Breast Cancer
Submitted by jwr@option4.com on Sat, 07/17/2010 - 21:05
Clinical Trials Evaluating the Role of Sentinel Node Resection (SNR) in Early-Stage Breast Cancer
Submitted by jwr@option4.com on Sat, 07/17/2010 - 21:03
5-Minute Journal Club — ASCO 2010 Presentations
Submitted by jwr@option4.com on Sat, 07/17/2010 - 20:33
Effects of Zoledronic Acid on Overall Survival in Newly Diagnosed Multiple Myeloma (MM)
Submitted by web@researchtop... on Fri, 07/09/2010 - 13:19
Lenalidomide Maintenance After Autologous Transplantation for Myeloma
Submitted by web@researchtop... on Fri, 07/09/2010 - 13:17
Novel Three-Drug Combinations of Bortezomib, Thalidomide, Dexamethasone and Lenalidomide for Newly Diagnosed Multiple Myeloma (MM)
Submitted by web@researchtop... on Fri, 07/09/2010 - 13:09
5-Minute Journal Club — ASCO 2010 Presentations
Submitted by web@researchtop... on Fri, 07/09/2010 - 12:47
5-Minute Journal Club — ASCO 2010 Presentations
Submitted by web@researchtop... on Wed, 07/07/2010 - 16:09
Lenalidomide as Initial Treatment for Elderly Patients with Chronic Lymphocytic Leukemia (CLL)
Submitted by jwr@option4.com on Wed, 07/07/2010 - 15:33
Complete Response Rates with Lenalidomide/Rituximab in the Front-Line Treatment of Indolent B-Cell Non-Hodgkin Lymphoma (NHL)
Submitted by jwr@option4.com on Wed, 07/07/2010 - 15:21
In Vivo Purging with Rituximab Before Stem Cell Collection and Maintenance Rituximab After Transplant for Patients with Relapsed Follicular Lymphoma (FL)
Submitted by jwr@option4.com on Wed, 07/07/2010 - 15:13
Maintenance Rituximab for Patients with Follicular Lymphoma (FL) Responding to Front-Line Induction with Rituximab/Chemotherapy
Submitted by jwr@option4.com on Wed, 07/07/2010 - 14:57